Showing results (191-200 of 240) with videos related to

Sort By:
Pageof 24
Chest|November 19, 2019
Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway AgentsVallerie V McLaughlin, Richard Channick, Teresa De Marco, et al.
Journal of the American College of Cardiology|October 25, 2024
Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary HypertensionYogesh N V Reddy, Robert P Frantz, Paul M Hassoun, et al.
Journal of the American College of Cardiology|March 12, 2021
Heart-After-Liver Transplantation Attenuates Rejection of Cardiac Allografts in Sensitized PatientsRichard C Daly, Andrew N Rosenbaum, Joseph A Dearani, et al.
The European Respiratory Journal|November 27, 2020
EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHARMarissa Borgese, David Badesch, Todd Bull, et al.
Circulation. Heart Failure|December 3, 2025
Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary HypertensionYogesh N V Reddy, Robert P Frantz, Anna R Hemnes, et al.
Chest|February 14, 2024
Health-Related Quality of Life Across the Spectrum of Pulmonary HypertensionAparna Balasubramanian, A Brett Larive, Evelyn M Horn, et al.
Journal of the American College of Cardiology|May 7, 2025
Disentangling the Impact of Adiposity From Insulin Resistance in Heart Failure With Preserved Ejection FractionYogesh N V Reddy, Robert P Frantz, Anna R Hemnes, et al.
Circulation. Heart Failure|May 29, 2025
Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary HypertensionYogesh N V Reddy, Robert P Frantz, Paul M Hassoun, et al.
Journal of the American College of Cardiology|February 9, 2018
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsRabea Asleh, Alexandros Briasoulis, Walter K Kremers, et al.
Pageof 24